Dermatological Drugs Market is projected to grow at a CAGR
Visiongain has published a new report entitled Dermatological Drugs Market Report 2024-2034: Forecasts by Route of Administration (Topical, Oral,...
Source: globenewswire.com
Biolojic Design News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Biolojic Design. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Biolojic Design Today - Breaking & Trending Today
Aulos Bioscience Advances AU-007 to Phase 2 Portion of Phase 1/2 Study Evaluating Computationally Designed IL-2 Antibody for Treatment of Solid Tumors
LARKSPUR, Calif.--(BUSINESS WIRE)--Dec 18, 2023--
Source: eagletribune.com
Teva buys rights for Israeli co Biolojic's asthma treatment
Biolojic is eligible to receive tiered royalties in "mid-single to low-double digit" millions of dollars on product sales should Teva successfully commercialize a therapy.
Source: globes.co.il
Teva Pharma To Receive Exclusive Rights To Develop, Manufacture And Commercialize BD9
Teva Pharmaceutical Industries Ltd., (TEVA) and Biolojic Design Ltd. announced an exclusive license agreement to develop a potential antibody-based therapy for the treatment of Atopic Dermatitis and Asthma.
Source: rttnews.com
New Phase 1 Dose Escalation Data Show Well-Tolerated Safety Profile and Anti-Tumor Activity for Aulos Bioscience's AU-007 at Society for Immunotherapy of Cancer (SITC) Annual Meeting | Region
LARKSPUR, Calif.--(BUSINESS WIRE)--Nov 3, 2023--
Source: eagletribune.com